# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-018352
Filing Date
2017-04-03
Accepted
2017-04-03 07:36:26
Documents
63
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | v462503_10k.htm | 10-K | 735525
2 | EXHIBIT 23.1 | v462503_ex23-1.htm | EX-23.1 | 2724
3 | EXHIBIT 23.2 | v462503_ex23-2.htm | EX-23.2 | 2075
4 | EXHIBIT 31.1 | v462503_ex31-1.htm | EX-31.1 | 7320
5 | EXHIBIT 31.2 | v462503_ex31-2.htm | EX-31.2 | 7322
6 | EXHIBIT 32.1 | v462503_ex32-1.htm | EX-32.1 | 4392
7 | EXHIBIT 32.2 | v462503_ex32-2.htm | EX-32.2 | 4410
14 | GRAPHIC | pg11img1_10k.jpg | GRAPHIC | 75314
15 | GRAPHIC | pg13img1_10k.jpg | GRAPHIC | 108039
16 | GRAPHIC | pg14img1_10k.jpg | GRAPHIC | 33471
17 | GRAPHIC | pg15img1_10k.jpg | GRAPHIC | 16568
18 | GRAPHIC | pg1img1_10k.jpg | GRAPHIC | 11270
| Complete submission text file | 0001144204-17-018352.txt |  | 5073072

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL INSTANCE DOCUMENT | mbrx-20161231.xml | EX-101.INS | 883346
9 | XBRL TAXONOMY EXTENSION SCHEMA | mbrx-20161231.xsd | EX-101.SCH | 49941
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | mbrx-20161231_cal.xml | EX-101.CAL | 31628
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mbrx-20161231_def.xml | EX-101.DEF | 316619
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mbrx-20161231_lab.xml | EX-101.LAB | 371348
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mbrx-20161231_pre.xml | EX-101.PRE | 351871

Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37758 | Film No.: 17732307
SIC: 2834 Pharmaceutical Preparations